Literature DB >> 31910074

The QIBA Profile for FDG PET/CT: Improving the Value of PET.

Gary A Ulaner1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 31910074      PMCID： PMC7051153          DOI： 10.1148/radiol.2019192409

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  9 in total

1.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

Review 2.  RECIST - learning from the past to build the future.

Authors:  Saskia Litière; Sandra Collette; Elisabeth G E de Vries; Lesley Seymour; Jan Bogaerts
Journal:  Nat Rev Clin Oncol       Date:  2016-12-20       Impact factor: 66.675

3.  Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib.

Authors:  Gary A Ulaner; Cristina Saura; Sarina A Piha-Paul; Ingrid Mayer; David Quinn; Komal Jhaveri; Ben Stone; Seta Shahin; Grace Mann; Melanie Dujka; Richard Bryce; Funda Meric-Bernstam; David B Solit; David M Hyman
Journal:  Clin Cancer Res       Date:  2019-09-23       Impact factor: 12.531

4.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

Review 5.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

6.  Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: influence of attenuation correction method and examination interval.

Authors:  Tomohito Kamibayashi; Tatsuro Tsuchida; Yoshiki Demura; Tetsuya Tsujikawa; Hidehiko Okazawa; Takashi Kudoh; Hirohiko Kimura
Journal:  Mol Imaging Biol       Date:  2008-04-12       Impact factor: 3.488

Review 7.  Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states.

Authors:  Sandip Basu; Habib Zaidi; Mohamed Houseni; Gonca Bural; Jay Udupa; Paul Acton; Drew A Torigian; Abass Alavi
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446

8.  The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy.

Authors:  Paul E Kinahan; Eric S Perlman; John J Sunderland; Rathan Subramaniam; Scott D Wollenweber; Timothy G Turkington; Martin A Lodge; Ronald Boellaard; Nancy A Obuchowski; Richard L Wahl
Journal:  Radiology       Date:  2020-01-07       Impact factor: 11.105

9.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.